Atlas Trials

Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

Clinical trial NCT00332709 · COMPLETED

Trial details

NCT number
NCT00332709
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
OsteoporosisPostmenopausal
Start date
2006-01-01
Primary completion
2010-08-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.